Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Ill., July 31, 2013 /PRNewswire/ -- Astellas Pharma Global Development, Inc. ("APGD"), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, welcomes Claire Thom, Pharm.D.,...
Read more about Astellas Appoints New Senior Vice President of Global Oncology Development
New initiative highlights the physical and emotional burden of overactive bladder through a unique mix of educational programs NORTHBROOK, Ill., July 24, 2013 /PRNewswire/ -- As part of its...
Read more about Astellas Helps Patients Identify with their "OAB Reality"
NORTHBROOK, Ill., July 19, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and...
NORTHBROOK, Ill., July 8, 2013 /PRNewswire/ -- On July 10, 2013, The Cove School in Northbrook, which serves children with learning disabilities from 60 school districts throughout the Chicagoland...
BOTHELL, Wash., & SANTA MONICA, Calif., June 27, 2013 – Seattle Genetics, Inc. (Nasdaq: SGEN) and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. (Tokyo:4503), today announced...
Follow U.S. news
